Transcriptional networks and cellular senescence in human mammary fibroblasts

被引:23
作者
Hardy, K
Mansfield, L
Mackay, A
Benvenuti, S
Ismail, S
Arora, P
O'Hare, MJ
Jat, PS [1 ]
机构
[1] UCL, Sch Med, Ludwig Inst Canc Res, London W1W 7BS, England
[2] Royal Free & Univ Coll Med Sch, Sch Med, Dept Surg, Breast Canc Lab,LICR,UCL, London W1P 7LD, England
[3] UCL, Dept Neurodegenerat Dis, Inst Neurol, London WC1N 3BG, England
基金
英国惠康基金;
关键词
D O I
10.1091/mbc.e04-05-0392
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Senescence, the molecular program that limits the finite proliferative potential of a cell, acts as an important barrier to protect the body from cancer. Techniques for measuring transcriptome changes and for modulating their expression suggest that it may be possible to dissect the transcriptional networks underlying complex cellular processes. HMF3A cells are conditionally immortalized human mammary fibroblasts that can be induced to under-go coordinated Senescence. Here, we used these cells in conjunction with microarrays, RNA interference, and in silico promoter analysis to promote the dissection of the transcriptional networks responsible for regulating cellular senescence. We first identified chancres in the transcriptome when HMF3A cells undergo senescence and then compared them with those observed upon replicative senescence in primary human mammary fibroblasts. In addition to DUSP1 and known p53 and E2F targets, a number of genes such as PHLDA1, NR4A3, and a novel splice variant of STAC were implicated in senescence. Their role in senescence was then analyzed by RNA silencing followed by microarray analysis. In silico promoter analysis of all differential genes predicted that nuclear factor-kappaB and C/EBP transcription factors are activated upon senescence, and we confirmed this by electrophoretic mobility shift assay. The results suggest a putative signaling network for cellular senescence.
引用
收藏
页码:943 / 953
页数:11
相关论文
共 62 条
[1]   Cellular transformation by SV40 large T antigen: interaction with host proteins [J].
Ali, SH ;
DeCaprio, JA .
SEMINARS IN CANCER BIOLOGY, 2001, 11 (01) :15-22
[2]   TELOMERE LENGTH PREDICTS REPLICATIVE CAPACITY OF HUMAN FIBROBLASTS [J].
ALLSOPP, RC ;
VAZIRI, H ;
PATTERSON, C ;
GOLDSTEIN, S ;
YOUNGLAI, EV ;
FUTCHER, AB ;
GREIDER, CW ;
HARLEY, CB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10114-10118
[3]   HUMAN-SKIN FIBROBLASTS INVITRO DIFFERENTIATE ALONG A TERMINAL CELL LINEAGE [J].
BAYREUTHER, K ;
RODEMANN, HP ;
HOMMEL, R ;
DITTMANN, K ;
ALBIEZ, M ;
FRANCZ, PI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (14) :5112-5116
[4]   Differential proteome analysis of replicative senescence in rat embryo fibroblasts [J].
Benvenuti, S ;
Cramer, R ;
Quinn, CC ;
Bruce, J ;
Zvelebil, M ;
Corless, S ;
Bond, J ;
Yang, A ;
Hockfield, S ;
Burlingame, AL ;
Waterfield, MD ;
Jat, PS .
MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (04) :280-292
[5]   Extension of life-span by introduction of telomerase into normal human cells [J].
Bodnar, AG ;
Ouellette, M ;
Frolkis, M ;
Holt, SE ;
Chiu, CP ;
Morin, GB ;
Harley, CB ;
Shay, JW ;
Lichtsteiner, S ;
Wright, WE .
SCIENCE, 1998, 279 (5349) :349-352
[6]   Stable suppression of tumorigenicity by virus-mediated RNA interference [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
CANCER CELL, 2002, 2 (03) :243-247
[7]   A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553
[8]   Dual specificity phosphatases: a gene family for control of MAP kinase function [J].
Camps, M ;
Nichols, A ;
Arkinstall, S .
FASEB JOURNAL, 2000, 14 (01) :6-16
[9]   Molecular analysis of H2O2-induced senescent-like growth arrest in normal human fibroblasts:: p53 and Rb control G1 arrest but not cell replication [J].
Chen, QM ;
Bartholomew, JC ;
Campisi, J ;
Acosta, M ;
Reagan, JD ;
Ames, BN .
BIOCHEMICAL JOURNAL, 1998, 332 :43-50
[10]   Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms [J].
Davis, T ;
Singhrao, SK ;
Wyllie, FS ;
Haughton, MF ;
Smith, PJ ;
Wiltshire, M ;
Wynford-Thomas, D ;
Jones, CJ ;
Faragher, RGA ;
Kipling, D .
JOURNAL OF CELL SCIENCE, 2003, 116 (07) :1349-1357